DAX+0,14 % EUR/USD-0,30 % Gold-0,10 % Öl (Brent)0,00 %

MYM Nutraceuticals Inc. - My Marijuana Canada Inc. - Die letzten 30 Beiträge


WKN: A2AFCN | Symbol: 0MY
1,770
C$
19.04.18
CSE
+3,51 %
+0,060 CAD

Beitrag schreiben

Begriffe und/oder Benutzer

 

http://www.mymarijuana.ca/MYM+Announces+Launch+of+Canadian+A…

"MYM Announces Launch of Canadian Awareness Campaign

APRIL 17, 2018
Vancouver, B.C., April 17, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce the launch of its Cannabis Awareness Campaign – “It all unfolds this summer”, focusing on topics surrounding the impending legalization of recreational cannabis.

The campaign will run for six months from April 1 to October 1, 2018, beginning in the province of Quebec followed by locations across Canada. The campaign will use billboard advertising with an accompanying online campaign both directing users to the website www.cannafacts.ca. The website will aim to create a dialogue on the impending legalization of recreational cannabis slated to occur this summer. Topics include: job creation, economic concerns, health risks, and production quality. The website will encourage users to participate in a nationwide discussion on issues surrounding the legalization of recreational cannabis that matter to them.

“Canadians have a lot of questions regarding the impending legalization of recreational cannabis. There is a lot of confusion about how legalization will impact our families and our communities. Our goal is to create a forum for the country to discuss issues that matter to them, to help clear the air surrounding legalization”, said Rob Gietl, CEO of MYM. “The cannafacts.ca website will encourage users to ask questions and express their concerns. Based on this feedback, MYM will create a newsletter that will continue the conversation using fact-based discussion and expert opinion”.

MYM engaged Vancouver based Signals – an award winning creative studio that develops creative and campaigns for local, national, and international clients.

..."
Man beachte die "Investitionssteuergutschrift in Quebec"
http://www.baystreet.ca/stockstowatch/3512/Meet-Canadas-Mass…

Quebec sieht aus wie ein kleines Steuerparadies;)
Antwort auf Beitrag Nr.: 57.520.286 von Nosleep am 11.04.18 18:34:46Das ist noch 'ne Nummer zu groß für MYM.
Die sales license wird denke ich frühestens Ende des Jahres kommen.
Und das sind dann ja auch erst mal nur ich glaube 16.000 sqf.

Bis Weedon und Australien produzieren ist noch ein gutes Stück länger hin.

Gruß, praesens
Antwort auf Beitrag Nr.: 56.631.329 von praesens am 05.01.18 18:08:26
So tickt usere Pharmalobby auch!!!
Zitat von praesens: "cannabislegalisierungsverbot" - interessante Wortschöpfung ... Legalisierungsverbot :laugh:;)

Was auch immer das ist - das gibt es nicht.

In Canada wird die recreational Legalisierung bestenfalls verschoben. Wenn überhaupt.
Das ist für MYM aber komplett egal, da MYM auf dem längst legalen medical markt aktiv ist.

Auch ein etwaige Rolle rückwärts in den USA betrifft MYM in keinster Weise.
Im Gegenteil - das könnte eine große Chance sein für kanadische Unternehmen weiterhin an Boden gut zu machen.

Ich glaube aber dass Leute wie Jeff Sessions sich in den USA nicht werden durchsetzen können.
Er bekam bereits heftigen Gegenwind aus dem Kongress - auch von Parteigenossen.

Meiner Meinung nach ist der gute Mann getrieben von der Pharmalobby die Milliarden an Umsatz den Bach runter gehen sieht.

Gruß, praesens


https://www.youtube.com/watch?v=kM0a3ddh7bQ

Ich hoffe nicht das es einer von uns es jemals braucht...aber gut zu wissen das es da was gibt!!!!

Mfg:Nosleep
Antwort auf Beitrag Nr.: 57.377.831 von Felga am 24.03.18 16:56:16Ja, denke schon.
Es würde ja auch auf der acmpr Seite veröffentlicht (wobei sich die Frage stellt wie tagesaktuell die sind).

Gruß, praesens
Antwort auf Beitrag Nr.: 57.377.480 von praesens am 24.03.18 15:48:31ja vielleicht vielleicht. ..Die Möglichkeit das MYM die Lizenz schon hat, aber mit Veröffentlichung erst auf ein wieder besseres Marktumfeld wartet is a Schmarrn - oder!?
Antwort auf Beitrag Nr.: 57.377.258 von Felga am 24.03.18 14:36:55... vielleicht gibt es Samstag eine Veröffentlichung, oder dann Montag ?

Vielleicht dauert es aber sowieso noch ein bisschen.
Eins ist sicher - die Lizenz ist sicher ;)
...also nach allem menschlichen Ermessen.

Gruß, praesens
....nächste Woche ist Ostern/Karfreitag, ebenfalls Feiertag in Kanada...wars das jetzt mit der angekündigten (Quartal) Lizenz für Laval!? Soweit ich es bisher mitbekommen hab vergibt HC die Lizenzen Freitagas oder gibt's /gab es schon Ausnahmen! ? Weiß jemand ob ein Unternehmen Einfluss auf die Bekanntgabe nehmen kann!? ....ich weiß Fragen über Fragen 😩😉
LEUTE !!! DER KANADISCHE SENAT HAT IN DER NUN SCHON ZWEITEN LESUNG FÜR DAS FÜR DIE ENDGÜLTIGE LEGALISIERUNG SO WICHTIGE BILL C-45 GESTIMMT !!! EIN WEITERER SCHRITT IST DAMIT ERREICHT !!!

Quelle:

http://www.huffingtonpost.ca/2018/03/22/senate-passes-marijuana-legalization-bill_a_23393062/
Bill C45 zum recreational cannabis ist mit 44 zu 29 Stimmen durch !

Gruß, praesens
Antwort auf Beitrag Nr.: 57.212.719 von praesens am 07.03.18 15:56:24Das hätte ich so auch nicht gedacht:

https://bc.ctvnews.ca/bright-lights-from-legal-langley-grow-…

"... Residents near a recently-licensed legal marijuana grow-op in Langley are complaining that the bright lights coming from the facility are disruptive ..."
Antwort auf Beitrag Nr.: 57.190.030 von praesens am 05.03.18 15:53:50https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aMYM-2578…

"ORIGINAL: MYM Appoints New Chief Science Officer

2018-03-07 09:25 ET - News Release

(via TheNewswire)

Vancouver, B.C. / TheNewswire / March 7, 2018 - MYM Nutraceuticals Inc. , (CSE: MYM ) (the "Company" or " MYM ") is pleased to announce Dr. Charith Adkar has joined MYM as its new Chief Science Officer (CFO) effective immediately.

Dr. Adkar completed his PhD in Plant Biology and Crop Production from the University of Milano, Italy with the specialization in Molecular Plant Pathology. He completed his postdoctoral studies at Hirosaki University, Japan and Universite de Sherbrooke, Canada. His areas of expertise include Plant Science, Biotechnology, Microbiology, Molecular host-pathogen interactions and Bioinformatics.

Dr. Adkar will manage MYM's scientific, research and technological operations. He will work primarily at the Laval and Weedon production facilities.

"We're extremely pleased to welcome Dr. Charith Adkar to the MYM team," said Rob Gietl, CEO of MYM. "Dr. Adkar will be instrumental in leading MYM to be a global innovator in the science and technology of medicinal cannabis. His proven track record and research in plant biology and crop production will ensure that MYM will be on the cutting edge of cannabis plant discovery and research."

Subject to the terms of the Company's stock option plan Dr. Adkar will received 75,000 options to purchase common shares of the company priced at $3.18. The options will vest as follows: 25,000 of the Stock Options will vest on the six (6) month anniversary of the Start Date; 25,000 of the Stock Options will vest on the twelve (12) month anniversary of the Start Date; and 25,000 of the Stock Options will vest on the eighteen (18) month anniversary of the Start Date. The options will expire (1) year after each vesting date.

..."
http://www.mymarijuana.ca/MYM+Receives+Permit+Approval+to+Be…

"MYM Receives Permit Approval to Begin Construction on Phase One of Weedon, Quebec Project

MARCH 5, 2018
Vancouver, B.C., March 5, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce the Municipality of Weedon, QC has approved the building permit to begin construction on the 1.5 million sqft greenhouse at the Weedon QC production facility.

MYM has received approval and commenced Phase One construction of the Weedon production facility. The projected date of completion for Phase One construction is the end of Q3, 2018. Phase One of the Weedon project will consist of building 300,000 sqft of greenhouse space for growing medical cannabis and 20,000 sqft for processing and manufacturing medical cannabis products. Phase One will be capable of producing 30,000 kgs annually.

“With the approved permits, architectural drawings and security plans already in place, MYM has commenced construction of the Weedon, QC project”, said Rob Gietl, CEO of MYM. ”This signifies a monumental milestone for MYM and our plans of building one of the largest greenhouses in the world. This project aligns with our goals of becoming a leading global cannabis producer.”

The Weedon facility is scheduled to be completed by the end of 2020. Complete build out will see greenhouse production space of 1.5 million sqft, capable of producing an estimated 150,000 kgs of cannabis.

..."
Antwort auf Beitrag Nr.: 57.174.072 von reznip1386 am 02.03.18 21:07:59... ja ...
Antwort auf Beitrag Nr.: 57.174.016 von praesens am 02.03.18 20:55:43Endlich geht's hier Kurs- und Newstechnisch wieder in die richtige Richtung.
War die letzten Wochen schon etwas frustrierend was im Cannabis-Sektor los war/ist...bin mal gespannt wie sich das bis Mitte des Jahres entwickelt :D
Hier das Text:

"MYM Continues Growth Plans on Australian Project

MYM Nutraceuticals Inc., (CSE:MYM) (the “Company” or “MYM”) is pleased to announce its consultant on the Australian project, Michael Horsfall, has renewed his agreement with MYM.

Mr. Horsfall is co-founder and CEO of PUF Ventures Australia Pty and Natures Hemp Australia Pty Ltd. He has worked extensively as a strategic business consultant with various Australian and Internationally listed fortune 100 companies and brings over 20 years’ experience to the role. He has been responsible for successfully leading pursuit and capture teams across Government and Whole-of-Government (WOG) IT Outsourcing Contracts for both Federal and State Governments. Mr. Horsfall has founded numerous companies in the Information Technology, Consulting, Finance, Hospitality and Real Estate sectors. He brings with him an extensive network and relationships combined with an in-depth understanding of business and Government.

“We are extremely fortunate to be working with Mr. Hosfall,” said Rob Gietl, CEO of MYM. “His experience consulting with Fortune 100 companies and navigating the various levels of Australian government will prove to be an asset in our stated goal of building a 1.2 million square foot greenhouse in Australia”.

Mr. Horsfall will be granted, effective today, 140,000 stock options (each an “Option”) of the Company in accordance with the Company’s current stock option plan. Each Option is exercisable into one common share (“a “Share”) of the Company at a price of $2.41 per Share for a period of 1 year from the vesting date. The options will vest over 27 months, with 14,000 vesting immediately and 14,000 on each three-month anniversary date thereafter.

The issuance of the Options is subject to the approval of the Canadian Stock Exchange. If the issuance of the options is approved by the Canadian Stock Exchange, the Options may be subject to a minimum hold period of 4 months and one day in accordance with applicable securities laws.

..."
http://www.mymarijuana.ca/MYM+Appoints+New+Chief+Financial+O…

"MYM Appoints New Chief Financial Officer

FEBRUARY 28, 2018
Vancouver, B.C., February 28, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce Craig Lennox has joined MYM as its new Chief Financial Officer (CFO) effective February 26, 2018. Lennox joins MYM from Clearly, a leading online optical retailer, where he was most recently Chief Financial Officer. Lennox is Chartered Professional Accountant (CA) and brings with him an extensive background in public accounting and broad experience in financial management.
“It is an exciting time to be entering into the cannabis space and I’m pleased to be joining the MYM team to help execute in bringing the various MYM projects to market,” commented Lennox.
Lennox will lead MYM’s financial operations, and will report directly to Rob Gietl, MYM’s CEO. Craig succeeds Mark Forster who will stay on with MYM in a supporting role.
Mr. Lennox was granted 800,000 options to purchase MYM common shares, pursuant to the Company’s Stock Option Plan. The options are exercisable for a period of two years, after they vest, at a price of $1.98 per share. 200,000 of the options will vest on February 26, 2019, and 50,000 every quarter thereafter.

..."
Antwort auf Beitrag Nr.: 57.135.816 von Frhstck am 27.02.18 17:54:031,22 - da muss erst Frhstck wieder kaufen damit was vorwärts geht
Zitat von Frhstck: Hab mir eben die erste Post zu 1,06 gekauft
Antwort auf Beitrag Nr.: 57.131.043 von Saftschubsee am 27.02.18 12:00:18In einem leichten Abwärtstrend :laugh::laugt: - die Bude ist von 3 auf 1 gefallen die letzten 2 Monate.
Zitat von Saftschubsee: MYM befindet sich zum jetztigen Zeitpunkt meines Erachtens in einem leichten Abwärtstrend. Ich bin hier selbst investiert und hoffe das so schnell wie möglich ein Boden gefunden ist und wir wieder nach oben Anziehen. Zur Zeit stagniert der komplette Mariuhana Sektor .. ein guter Zeitpunkt um nachzu kaufen , m.E.
Es wird wieder nach oben gehen in Zukunft. MYM und Cannabis im Allgemein haben ein riesiges Potential.


Beitrag zu dieser Diskussion schreiben